Resolutions

All English translations are courtesy translations only. Only the German versions are binding.

Resolution of 18 April 2013: Pharmaceuticals on the existing market (58.4 kB)
Justification of the resolution of 18 April 2013 (214.9 kB)

Resolution of 17 April 2014: Discontinuation of benefit assessments of pharmaceuticals on the existing market (40.6 kB)

 

Page
Active Substance Name Therapeutic Area Date of Resolution
Pixantrone dimaleate (78.2 kB) Pixuvri® Lymphoma, Non-Hodgkin 16/05/2013
Pomalidomide (77.3 kB) Imnovid® Multiple Myeloma 20/02/2014
Ponatinib (77.9 kB) Iclusig® Leukemia, Lymphoid; Leukemia, Myeloid 23/01/2014
Regadenoson (45.6 kB) Rapiscan® Myocardial Perfusion Imaging 29/03/2012
Regorafenib (92.1 kB) Stivarga® Colorectal Neoplasms 20/03/2014
Retigabine (36.2 kB) Trobalt® Epilepsy 03/05/2012
Rilpivirine (72.7 kB) Edurant® HIV Infections 05/07/2012
Ruxolitinib (114.0 kB) Jakavi® Myeloproliferative Disorders 07/03/2013
Saxagliptin (182.3 kB) Onglyza® Diabetes Mellitus, Type 2 01/10/2013
Saxagliptin/metformin (148.5 kB) Komboglyze® Diabetes Mellitus, Type 2 02/05/2013
Saxagliptin/metformin (new therapeutic indication) (94.8 kB) Komboglyze® Diabetes Mellitus, Type 2 01/10/2013
Simeprevir (288.9 kB) Olysio® Hepatitis C, Chronic 20/11/2014
Sitagliptin (180.0 kB) Januvia®, Xelevia® Diabetes Mellitus, Type 2 01/10/2013
Sitagliptin/metformin (153.5 kB) Janumet®, Velmetia® Diabetes Mellitus, Type 2 01/10/2013
Sofosbuvir (298.8 kB) Sovaldi® Hepatitis C, Chronic 17/07/2014
Tafamidis meglumine (35.2 kB) Vyndaqel® Amyloidosis 07/06/2012
Tegafur, Gimeracil, Oteracil (80.9 kB) Teysuno® Stomach Neoplasms 20/12/2012
Telaprevir (108.4 kB) Incivo® Hepatitis C 29/03/2012
Teriflunomide (91.6 kB) Aubagio® Multiple Sclerosis 20/03/2014
Ticagrelor (100.1 kB) Brilique® Acute Coronary Syndrome Peripheral Vascular Diseases 15/12/2011
Trastuzumab emtansine (171.2 kB) Kadcyla® Breast Neoplasms 19/06/2014
Turoctocog alfa (83.6 kB) NovoEight® Hemophilia A 03/07/2014
Umeclidinium bromide/vilanterol (114.1 kB) Anoro®, Laventair® Pulmonary Disease, Chronic Obstructive 08/01/2015
Vandetanib (52.0 kB) Caprelsa® Thyroid Neoplasms 06/09/2012
Vedolizumab (102.3 kB) Entyvio® Colitis, Ulcerative Crohn Disease 08/01/2015
Vemurafenib (89.0 kB) Zelboraf® Melanoma 06/09/2012
Vildagliptin (167.0 kB) Galvus®, Jalra®, Xiliarx® Diabetes Mellitus, Type 2 01/10/2013
Vildagliptin/metformin (132.7 kB) Eucreas®, Icandra®, Zomarist® Diabetes Mellitus, Type 2 01/10/2013
Vismodegib (102.8 kB) Erivedge® Carcinoma, Basal Cell 06/02/2014
Page